Literature DB >> 23018719

Speech outcome after palatal repair in nonsyndromic versus syndromic Robin sequence.

Kamlesh B Patel1, Stephen R Sullivan, Ananth S Murthy, Eileen Marrinan, John B Mulliken.   

Abstract

BACKGROUND: The authors' purpose was to document speech outcome after cleft palate repair in patients with syndromic versus nonsyndromic Robin sequence. Results of secondary correction of velopharyngeal insufficiency using a superiorly based pharyngeal flap or double-opposing Z-palatoplasty are also reported.
METHODS: Charts of patients with Robin sequence and cleft palate between 1980 and 2007 were reviewed. Data collected included date of birth, sex, syndrome/association, cleft palatal type (Veau I or II), age at palatoplasty, incidence of palatal fistula, postoperative speech assessment, videofluoroscopic results, need for secondary operation for velopharyngeal insufficiency, and type of secondary operation (pharyngeal flap or double-opposing Z-palatoplasty).
RESULTS: The authors identified 140 patients with Robin sequence who had palatal closure. Postoperative speech evaluation was available for 96 patients (69 percent). A syndrome or association was identified in 42 patients (30 percent). Primary palatoplasty was successful in 74 patients (77 percent); speech was characterized as competent and competent to borderline competent. The authors found a significantly higher incidence of velopharyngeal insufficiency following palatal repair for syndromic (38 percent) than nonsyndromic Robin sequence (16 percent). (p = 0.039). In patients with velopharyngeal insufficiency, competent or borderline competent speech was determined after double-opposing Z-palatoplasty (two of five patients) or pharyngeal flap (eight of 10 patients).
CONCLUSIONS: The rate of velopharyngeal insufficiency in syndromic Robin sequence is significantly greater than in nonsyndromic Robin sequence. The authors prefer pharyngeal flap for velopharyngeal insufficiency in patients with Robin sequence, whether syndromic or nonsyndromic, without retrognathism or signs/symptoms of obstructive sleep apnea.

Entities:  

Mesh:

Year:  2012        PMID: 23018719     DOI: 10.1097/PRS.0b013e318262f2e4

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  6 in total

1.  Clinical and Molecular Characterisation of Children with Pierre Robin Sequence and Additional Anomalies.

Authors:  Jessie X Xu; Nicky Kilpatrick; Naomi L Baker; Anthony Penington; Peter G Farlie; Tiong Yang Tan
Journal:  Mol Syndromol       Date:  2016-09-15

2.  Timing of Cleft Palate Repair in Patients With and Without Robin Sequence.

Authors:  Gary B Skolnick; Matthew R Keller; Ethan J Baughman; Dennis C Nguyen; Katelin B Nickel; Sybill D Naidoo; Margaret A Olsen; Kamlesh B Patel
Journal:  J Craniofac Surg       Date:  2021-05-01       Impact factor: 1.046

3.  Severity of Retrognathia and Glossoptosis Does Not Predict Respiratory and Feeding Disorders in Pierre Robin Sequence.

Authors:  Anne Morice; Véronique Soupre; Delphine Mitanchez; Francis Renault; Brigitte Fauroux; Sandrine Marlin; Nicolas Leboulanger; Natacha Kadlub; Marie-Paule Vazquez; Arnaud Picard; Véronique Abadie
Journal:  Front Pediatr       Date:  2018-11-20       Impact factor: 3.418

4.  Long-term Speech Outcomes of Cleft Palate Repair in Robin Sequence versus Isolated Cleft Palate.

Authors:  Robrecht J H Logjes; Susanna Upton; Bryce A Mendelsohn; Ryan K Badiee; Corstiaan C Breugem; William Y Hoffman; Jason H Pomerantz
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-01-21

5.  Pierre Robin sequence: Subdivision, data, theories, and treatment - Part 4: Recommended management and treatment of Pierre Robin sequence and its application.

Authors:  Kurt-W Bütow; Sharan Naidoo; Roger Arthur Zwahlen; Jean A Morkel
Journal:  Ann Maxillofac Surg       Date:  2016 Jan-Jun

6.  Chromosomal microarray analysis in the prenatal diagnosis of orofacial clefts: Experience from a single medical center in mainland China.

Authors:  Han Jin; Cui Yingqiu; Liu Zequn; Huang Yanjun; Zhang Yunyan; Zhao Shufan; Chen Yiyang; Li Ru; Zhen Li; Zhang Yongling; Wang Hongtao; Liao Can
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.